Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IntraVenous NAC for respiratory diseases with abnormal mucus secretion (China, Phase 3)
CTR20190436Phase 3Completed
- Sponsor
- Zambon
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in acute bronchitis, chronic bronchitis (CB), chronic obstructive pulmonary disease (COPD), emphysema, bronchiectasis, sponsored by Zambon. Started Apr 2019; status: completed.
02
Drugs
acetylcysteine
03
Conditions
acute bronchitischronic bronchitis (CB)chronic obstructive pulmonary disease (COPD)emphysemabronchiectasis
Beyond the preview
Go deeper on CTR20190436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190436.